Market Scope –
The continuous renal replacement treatment market size is anticipated to reach USD 2,982.63 million by 2030, at an 8.9% CAGR over the forecast period (2022- 2030).
The Continuous Renal Replacement Therapy (CRRT) Market is witnessing steady growth as it addresses the critical needs of patients with acute kidney injury. CRRT offers a continuous and slow process of blood purification, ensuring a gradual removal of waste and excess fluid from the body. This method is particularly crucial for patients with compromised renal function, providing a gentle and continuous treatment option. The market's expansion is fueled by the increasing incidence of acute kidney injury, rising awareness about advanced renal care, and technological advancements in CRRT systems. As healthcare systems prioritize patient outcomes, CRRT emerges as a vital therapy for renal support.
Segmentation –
The global continuous renal replacement therapy market trend has undergone segmentation based on product, modality, age group, and end user.
In terms of product, the market has been categorized into dialysates and replacement fluids, disposables, and CRRT systems. Dialysates and replacement fluids are anticipated to dominate the market during the forecast period, given their frequent use in CRRT systems. The segment's growth is further fueled by the varied fluid requirements for different therapies.
The modality segment includes continuous venovenous hemofiltration (CVVH), continuous venovenous diafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). Continuous venovenous hemofiltration is expected to lead the market share in 2021, particularly for patients who find hemodialysis less suitable. Additionally, CVVH therapy experienced a surge in adoption during the pandemic.
Age group segmentation comprises geriatric, adults, and pediatric neonates. In 2021, adults are anticipated to hold the largest market share, reflecting the increasing incidence of kidney-related diseases in developing regions within this age group.
Finally, the market has been segmented by end user into hospitals, ambulatory surgical centers, and specialty clinics. Hospitals are poised for lucrative growth opportunities, driven by an uptick in cardiac surgical procedures and the rising prevalence of kidney-related diseases.
Regional Analysis –
The North America region is poised to lead the continuous renal replacement therapy market during the forecast period, driven by factors such as an increasingly sedentary lifestyle, physical inactivity, and strategic collaborations among regional market players. Sedentary lifestyles and physical inactivity contribute to the risk of diabetes, obesity, and heart failure, with atrial fibrillation patients being more prone to acute kidney injury. According to the Centers for Disease Control and Prevention, there were 183,321 deaths attributed to atrial fibrillation in 2019.
The Europe continuous renal replacement therapy market is expected to experience substantial growth, fueled by the rising prevalence of arrhythmia and other cardiovascular diseases, an increase in cardiac surgical procedures, and the ongoing development of healthcare infrastructure.
The Asia-Pacific market is anticipated to exhibit the fastest growth due to factors such as a growing geriatric population, overall population expansion, and a rise in physical inactivity and sedentary lifestyles. A significant portion of the Asia-Pacific workforce adopts a sedentary lifestyle, leading to increased risks of obesity and diabetes, consequently elevating the likelihood of developing cardiovascular diseases and acute kidney failure.
In the Rest of the World, the market is projected to demonstrate sluggish growth due to a shortage of physicians practicing continuous renal replacement therapy. Nonetheless, the increasing prevalence of cardiovascular diseases, including ischemic heart disease and rheumatic heart disease in Africa and Latin America, heightens the risk of acute kidney failure, contributing to market growth.
Key Players –
Continuous renal replacement therapy companies include Baxter International, Inc. (US), Medtronic plc (Ireland), Fresenius Medical Care (US), B. Braun Medical Inc. (US), Nikkiso Co. (Japan), Asahi Kasei Corporation (Japan), Toray Medical Co. Ltd (Japan), Infomed SA (Switzerland), SWS Heamodialysis Care Co. Ltd (China), Medites Pharma spol. s.r.o. (Czech Republic), and other notable contributors.
Related Reports –
mobile tablets healthcare market
helicobacter pylori test market
transarterial chemoembolization market
For more information visit at MarketResearchFuture
